CAMBRIDGE, Mass. , Oct. 03, 2022 (GLOBE NEWSWIRE) — Voyager Therapeutics , Inc. (Nasdaq: VYGR), a gene therapy and neuroscience company developing life-changing treatments and next-generation adeno-associated virus (AAV) capsids, today announced that it will present three posters at the upcoming

Reader Interactions

Leave A Reply